Cue Biopharma Inc buy Stifel Nicolaus
Start price
22.03.23
/
50%
€3.00
Target price
22.03.24
€7.41
Performance (%)
-42.17%
End price
23.03.24
€1.74
Summary
This prediction ended on 23.03.24 with a price of €1.74. Massive losses of -42.17% were the result for the BUY prediction by Stifel_Nicolaus. Stifel_Nicolaus has a follow-up prediction for Cue Biopharma Inc where he still thinks Cue Biopharma Inc is a Buy. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cue Biopharma Inc | 3.401% | 3.401% | -59.249% |
iShares Core DAX® | 0.597% | 3.083% | 16.090% |
iShares Nasdaq 100 | 0.899% | 5.338% | 29.239% |
iShares Nikkei 225® | 1.775% | -1.206% | 6.823% |
iShares S&P 500 | 0.990% | 3.500% | 24.956% |
Comments by Stifel_Nicolaus for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target lowered by analysts at Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten